Epimedin A1 significantly elevates RvD5 levels in colonic tissue, suppresses CXCL8 expression in colonic epithelial cells, and reduces mucosal epithelial neutrophil infiltration in colitis mice. This evidence concerns the gene CXCL8 and colitis.